ddrg/super_eurlex huggingface dataset:
Prior notification of a concentration

(Case M.10686 – LOV GROUP / BETCLIC EVEREST GROUP)

Candidate case for simplified procedure

(Text with EEA relevance)

(2022/C 208/06)

1. On 13 May 2022, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Lov Group Invest (‘Lov Group’, France), — Betclic Everest Group (‘BEG’, France), currently owned by Lov Group and Société des Bains de Mer de Monaco (‘SBM’, Monaco). Lov Group will acquire within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the whole of BEG. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are the following: — Lov Group: investment firm mainly active in the production of audio-visual content, the online gambling sector through its currently jointly controlled subsidiary BEG as well as in the luxury hotel and food sectors, — BEG: provision of online sports betting, casino games, poker and horse racing.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.10686 – LOV GROUP / BETCLIC EVEREST GROUP Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Official Journal of the European Union

Prior notification of a concentration

(Case M.10746 – MORGAN STANLEY / BAWAG / GYLE JV)

Candidate case for simplified procedure

(Text with EEA relevance)

(2022/C 201/07)

1. On 6 May 2022, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Morgan Stanley Principal Funding, Inc. (‘MSPF’), belonging to the Morgan Stanley Group (‘Morgan Stanley’’, both United States), — RF zwölf BAWAG Leasing Gesellschaft m.b.H (‘Bawag Leasing’), belonging to the Bawag Group AG (‘BAWAG Group’, both Austria), — Gyle JV which has been set up for the purpose of the acquisition of the Gyle Shopping Centre (United Kingdom). MSPF and Bawag Leasing will acquire within the meaning of Article 3(1)(b) of the Merger Regulation indirectly through Gyle JV joint control over the Gyle Shopping Centre from DRC Capital LLP (‘DRC’). The concentration is accomplished by way of purchase of shares and obligations.

2. The business activities of the undertakings concerned are the following: — for MSPF: MSPF belongs to Morgan Stanley, a global financial services firm providing a wide range of investment banking, securities, wealth management and investment management services, — for Bawag Leasing: Bawag Leasing is part of Bawag Group, a publicly listed holding company, offering savings, payment, lending, leasing investment, building society, factoring and insurance products and services. — Gyle JV will be active in owning, managing, leasing, improving and developing the Gyle Shopping Centre located in Edinburgh, United Kingdom, as well as dealing with services related to the provision of retail space within the Gyle Shopping Centre.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.10746 – MORGAN STANLEY / BAWAG / GYLE JV Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Official Journal of the European Union

Prior notification of a concentration

(Case M.10717 – KKR / PAI PARTNERS / BCI / REFRESCO)

(Text with EEA relevance)

(2022/C 218/09)

1. On 23 May 2022, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — KKR & Co. Inc. (‘KKR’, US), — PAI Partners S.à.r.l. (PAI Partners, France), controlled by PAI Partners S.A.S., — British Columbia Investment Management Corporation (‘BCI’, Canada), — Refresco Deutschland Holding GmbH (‘Refresco’, Netherlands), controlled by PAI Partners and BCI. KKR, PAI Partners and BCI will acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of the whole of Refresco. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are the following: — KKR is a global investment firm that offers alternative asset management and capital markets and insurance solutions, — PAI Partners is active in the management of a number of funds investing in the business services, distribution, food & consumer, general industrials, and healthcare sectors, — BCI is an agent of the Government of British Columbia investing on behalf of public sector clients across a range of asset classes, including fixed income, public equities, private equity, infrastructure, renewable resources, real estate and commercial mortgages, — Refresco is global player active in the production and bottling of a large variety of non-alcoholic beverages for private label belonging to retailers and for brand owners under contract manufacturing.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.10717 – KKR / PAI PARTNERS / BCI / REFRESCO Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).
Official Journal of the European Union

Prior notification of a concentration

(Case M.10709 – PARTNERS GROUP / FORTERRO)

(Text with EEA relevance)

(2022/C 210/16)

1. On 17 May 2022, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Partners Group AG (‘Partners Group’, Switzerland) — Jeeves Information Systems AB (‘Forterro’, Sweden) Partners Group will acquire within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the whole of Forterro. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are the following: — for Partners Group: providing international institutional investors seeking direct access to private market assets with a wide range of investment funds and portfolios tailored to the investors’ needs, — For Forterro: provision of business software and IT solutions, focusing on the supply of enterprise resource planning software solutions to mid-market manufacturing and production companies.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.10709 – PARTNERS GROUP / FORTERRO Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).
Non-opposition to a notified concentration

(Case M.10662 – ATLANTIA / YUNEX)

(Text with EEA relevance)

(2022/C 228/03)

On 7 June 2022, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10662. EUR-Lex is the online point of access to European Union law.

(1) OJ L 24, 29.1.2004, p. 1.
Prior notification of a concentration

(Case M.10575 – BOUYGUES / EQUANS)

(Text with EEA relevance)

(2022/C 223/06)

1. On 30 May 2022, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Bouygues S.A. (‘Bouygues’, France), — Equans S.A.S. (‘Equans’, France). Bouygues will acquire within the meaning of Article 3(1)(b) of the Merger Regulation control of the whole of Equans. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are the following: — Bouygues is a holding company of a diversified industrial group active in the construction, transport infrastructure construction and maintenance, real estate development, media and telecommunications sectors. Bouygues also provides electrical engineering services through Colas Rail, a wholly owned subsidiary of Colas. Colas Rail provides electrical engineering services for railway infrastructures, including railway electrification (installation and maintenance of catenaries and overhead contact lines) and railway signalling. — Equans is a global company active in the multi-technical services sector. Equans’ activities focus on electrical, mechanical and heat, ventilation and air-conditioning engineering, refrigeration solutions, facility management, and digitization and Information and Communication Technology. Equans also provides railway electrification services (installation and maintenance of catenaries and overhead contact lines) through Powerlines, Ineo SCLE Ferroviaire and Fabricom.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.10575 – BOUYGUES / EQUANS Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).
Non-opposition to a notified concentration

(Case M.10729 – FOWI / MOL / TOHO / HOKURIKU / ORSTED / JERA / SWA)

(Text with EEA relevance)

(2022/C 240/03)

On 16 June 2022, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10729. EUR-Lex is the online point of access to European Union law.

(1) OJ L 24, 29.1.2004, p. 1.
Non-opposition to a notified concentration

(Case M.10743 – TOWERBROOK / GSF)

(Text with EEA relevance)

(2022/C 234/01)

On 8 June 2022, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10743. EUR-Lex is the online point of access to European Union law.

(1) OJ L 24, 29.1.2004, p. 1.
Non-opposition to a notified concentration

(Case M.10723 – BROOKFIELD / JINDAL GROUP / JINDAL PLASTIC FILMS BUSINESS)

(Text with EEA relevance)

(2022/C 246/02)

On 21 June 2022, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10723. EUR-Lex is the online point of access to European Union law.

(1) OJ L 24, 29.1.2004, p. 1.
Official Journal of the European Union

Prior notification of a concentration

(Case M.10749 – PAI PARTNERS / THE CARLYLE GROUP / THERAMEX)

(Text with EEA relevance)

(2022/C 243/10)

1. On 20 June 2022, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — PAI Partners SAS (‘PAI Partners’, France), — The Carlyle Group, Inc. (‘Carlyle’, US), — Theramex Healthcare Topco Limited (‘Theramex’, UK). PAI Partners and Carlyle will acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint control of the whole of Theramex. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are the following: — PAI Partners is a private equity firm that manages a number of funds investing in the business services, food & consumer, general industrials, and healthcare sectors, — Carlyle is a global alternative asset manager, which manages funds that invest globally across three investment disciplines: (i) Global Private Equity (including corporate private equity, real estate and natural resources funds); (ii) Global Credit (including liquid credit, illiquid credit and real assets credit); and (iii) Investment Solutions (private equity fund of funds program, which include primary fund, secondary and related co-investment activities), — Theramex is a global specialty pharmaceutical company active in women’s health, which focuses on contraception, fertility, menopause and osteoporosis. The company markets a broad range of branded and branded generic products across numerous countries in the EEA and globally.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.10749 – PAI PARTNERS / THE CARLYLE GROUP / THERAMEX Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).
Non-opposition to a notified concentration

(Case M.10741 – HG / EFMS / TA / IFS)

(Text with EEA relevance)

(2022/C 262/01)

On 27 June 2022, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10741. EUR-Lex is the online point of access to European Union law.

(1) OJ L 24, 29.1.2004, p. 1.
Non-opposition to a notified concentration

(Case M.10698 – MITSUI / INDOMOBIL / PTL / JV)

(Text with EEA relevance)

(2022/C 255/01)

On 17 June 2022, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10698. EUR-Lex is the online point of access to European Union law.

(1) OJ L 24, 29.1.2004, p. 1.
Prior notification of a concentration

(Case M.10784 – BAIN CAPITAL / BPEA / CITIUSTECH)

Candidate case for simplified procedure

(Text with EEA relevance)

(2022/C 271/13)

1. On 6 July 2022, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Bain Capital Investors L.L.C. (‘Bain Capital’, USA), — Baring Private Equity Asia (‘BPEA’, Hong Kong and Singapore), — CitiusTech Healthcare B.V. (‘CitiusTech’, the Netherlands), including its subsidiary CitiusTech Healthcare Technology Private Limited and its subsidiaries (‘CT India’) (together the ‘Target’). Bain Capital and BPEA will acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of the Target (the ‘Transaction’). The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are the following: — for Bain Capital: private equity investment firm that invests in companies across a number of industries, including information technology, healthcare, retail and consumer products, communications, financial services and industrial/manufacturing, — for BPEA: Pan-Asian private markets firm. The BPEA group manages a private equity investment program, sponsoring buyouts and providing growth capital to companies for expansion or acquisitions with a particular focus on the Asia Pacific region, as well as dedicated funds focused on private real estate and private credit, — for the Target: CitiusTech is a holding company with an approximately 80 % interest in CT India, which is an India-based healthcare technology services and solutions provider. CT India provides healthcare software engineering, healthcare professional services, healthcare QA test automation, healthcare technology consulting, healthcare BI/analytics and business and process outsourcing services in healthcare.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.10784 – BAIN CAPITAL / BPEA / CITIUSTECH Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.